Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling
| Autor: | Dimitrios Th. Kremastinos, Dimitrios Farmakis, Panagiotis Efentakis, Anastasia Zoga, Emmanuel Mastromanolis, Efstathios K. Iliodromitis, Nikolaos Papaioannou, Ioanna Andreadou, Sofia-Iris Bibli |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Intracellular Fluid
Male Myocardial Infarction Myocardial Ischemia Ischemia Angiotensin II receptor antagonist Pharmacology Wortmannin chemistry.chemical_compound Enos Animals Medicine Protein kinase B Cardioprotection biology business.industry medicine.disease biology.organism_classification Angiotensin II Carotid Arteries Valsartan chemistry Anesthesia Ischemic Preconditioning Myocardial Rabbits Cardiology and Cardiovascular Medicine business Signal Transduction medicine.drug |
| Zdroj: | International Journal of Cardiology. 184:140-151 |
| ISSN: | 0167-5273 |
| Popis: | Background We investigated the effectiveness of perconditioning (Perc) applied at different time points along with the role of RISK, SAFE, STAT5 and eNOS pathways. Methods and results Anesthetized rabbits were subjected to 30-min ischemia/3-hour reperfusion. Perc, consisted of 4cycles of 1-min ischemia/reperfusion, was applied in the carotid artery at different time points. Perc was started and ended during ischemia, started during ischemia and ended at the beginning of reperfusion, started at the end of ischemia and ended at reperfusion and started and ended during reperfusion. The PI3K inhibitor wortmannin, or the JAK-2 inhibitor AG490, was also applied and the infarct size was assessed. In another series assigned to the previous groups, the phosphorylation of Akt, PI3K, ERKs1/2, GSK3β, STAT3, and STAT5 was evaluated. All Perc groups had smaller infarction compared to those without Perc, independently of PI3K or JAK-2 inhibition. STAT5 was the only molecule that was phosphorylated in parallel with cardioprotection. Since Src and angiotensin II mediate the STAT5 pathway, we administered the Scr inhibitor PP1 and the angiotensin II receptor antagonist valsartan. PP1 and valsartan prevented STAT5 phosphorylation, but did not abrogate the effect of Perc. Furthermore, the NOS inhibitor L-NAME was administered and abrogated the infarct size limiting effect of Perc. In parallel, the expression of cleaved caspase-3 was elevated only in the control and Perc-A-L-NAME groups. Conclusion Perc reduces infarction independently of RISK, SAFE and STAT5 pathways. Src kinase and angiotensin II play a predominant role in STAT5 activation. eNOS may protect the myocardium through inhibition of apoptosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect